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Organismal diet has a profound impact on tissue homeostasis and health in mammals. Adult stem cells are a
keystone of tissue homeostasis that alters tissue composition by balancing self-renewal and differentiation
divisions. Because somatic stem cells may respond to shifts in organismal physiology to orchestrate tissue
remodeling and some cancers are understood to arise from transformed stemcells, there is a likely possibility
that organismal diet, stem cell function, and cancer initiation are interconnected. Here we will explore the
emerging effects of diet on nutrient-sensing pathways active in mammalian tissue stem cells and their
relevance to normal and cancerous growth.Introduction
Organismal diet is one of several lifestyle factors that influence
health and disease, such as cancer incidence and progression.
Food consumption can directly affect the availability of nutrients
and indirectly modulate growth factor and hormone levels, which
in turn can regulate tissue homeostasis and tumor initiation
(Rafalski et al., 2012). Historically, the effects of diet-induced
physiology in rodents have been audited by using two extremes
of nutrient availability: calorie restriction and dietary or genetic
models of obesity. Calorie restriction (also referred to as dietary
restriction) in many animal models is defined as a reduction in
nutrient intake on the order of 20% to 40% of total caloric intake,
without causing malnutrition (Johnson et al., 2013). Interestingly,
calorie restriction is associated with improved health (i.e.,
delayed onset of age-related pathologies), enhanced lifespan,
or both in multiple species ranging from worms to mammals
(Colman et al., 2009; Kenyon, 2010; Signer and Morrison,
2013). In contrast, obesity is associated with multiple comorbid-
ities that include heart disease, metabolic syndrome, and cancer
incidence. Because calorie restriction and obesity are on the
opposite ends of the spectrum in regards to calorie intake, the
physiologic state induced by each intervention will probably
have different or opposing effects on pathways that are engaged
in adult mammalian stem cells.
In this Review, we explore the influence of diet and metabolic
pathway regulation on adult stem cell biology in mammals and
the subsequent implications of these factors in cancer initiation.
From epidemiologic data, it has been long observed that diet in-
fluences cancer initiation in multiple species including humans;
yet, little is known about how diet at the cellular level regulates
somatic stem cell function and how this influences the predispo-
sition of these cells to undergo transformation. One can specu-
late that dietary interventions that increase the size of somatic
stem cell pools may over the long-term augment the probability
of developing a cancer, whereas dietary interventions that
reduce the size of the stem cell pool may be associated with a292 Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc.reduction in cancer incidence. From a preventative or regenera-
tive medicine perspective, a goal will be to develop nutritional
interventions or therapies that mimic the metabolic effects of
diets that enhance tissue regeneration without increasing the
risk of developing cancer.
Adult Stem Cells: Units of Tissue Adaptation and Early
Transformation
Many mammalian tissues are maintained by stem cells that
possess two defining characteristics: (1) the capacity to self-
renew and generate more stem cells that persist for the life of
an organism and (2) the ability to differentiate into downstream
progenitor cells that engender the cellular diversity inherent to
tissues. At the base of the intestinal crypt are rare Lgr5+ cells
that mark the majority of intestinal stem cells (ISCs), which drive
the 3 to 5 day turnover of the intestine (Barker et al., 2007, 2012).
Hematopoietic stem cells (HSCs) reside in the bone marrow and
give rise to all of the mature lymphoid, myeloid, and erythroid
blood cell types. Muscle regeneration is mediated by satellite
cells, which reside juxtaposed to mature myofibrils (Sherwood
et al., 2004). The satellite cell pool contains self-renewingmuscle
stem cells that can regenerate muscle tissue in response to
damage (Brack and Rando, 2012). Neural stem cells reside
in the central (CNS) and peripheral nervous systems (PNS) and
generate diverse neural subtypes important for memory and
gastrointestinal motility during fetal development or in adult
mammals (Kruger et al., 2002; Zhang et al., 2008). In addition,
stem cells exist in many other tissues including the epidermal
skin, sweat glands, liver, and stomach (Barker et al., 2010;
Huch et al., 2013; Lu et al., 2012; Snippert et al., 2010). The
balance between stem cell self-renewal and differentiation is a
key determinant of tissue homeostasis and allows stem cells to
dynamically remodel tissues in response to turnover, damage,
and disease.
Often the initial steps leading to transformation occur in so-
matic stem cells (Magee et al., 2012b; Miyamoto et al., 2000).
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tors derived from them, accumulate additional genetic or epige-
netic changes that lead to frank cancers. This process is best
illustrated in the mammalian intestine, where activation of b-cat-
enin (an early step in colon carcinogenesis) in Lgr5+ ISCs, but not
in non-Lgr5+ cells, is sufficient to induce the precursor adenoma-
tous lesions that evolve into intestinal carcinomas (Barker et al.,
2009; Zhu et al., 2009). A similar paradigm exists in the he-
matopoietic system (Chao et al., 2008). For instance, in chronic
myelogenous leukemia (CML), CML HSCs possess the BCR-
ABL translocation and only these CML HSCs (and not other
CML progenitor populations) can transfer disease in transplan-
tation assays (Jamieson et al., 2004b; Passegue´ et al., 2004).
Ultimately, transformation to CML-blast crisis or frank cancer
is believed to occur in downstream progenitors of the CML-
HSC (Jamieson et al., 2004a). Another example is the expression
of the leukemia AML1/ETO translocation in nonleukemic HSCs
(Miyamoto et al., 2000). The presence of a leukemic transloca-
tion in nonleukemic HSCs bolsters the notion that initial onco-
genic events occur in stem cells and that leukemia arises
when the progeny of premalignant HSCs (i.e., stem cells or
restricted progenitors) accumulate additional oncogenic insults.
Collectively, these findings suggest that tissue stem cells may
not only be key units of regeneration, but also substrates that
undergo events leading to transformation.
Intrinsic and Extrinsic Physiology-Sensing in Stem Cells
Diet-induced physiologic cues are likely to influence stem cell
biology and these can be partitioned into short-range signals
(local signals) and long-range signals (circulating growth factors)
as reviewed in Nakada et al. (2011). Stem cells often reside in
unique cellular neighborhoods or niches in diverse tissues,
allowing for their precise regulation by local cues. Lgr5+ ISCs,
for instance, are nestled between Paneth cells at the bottom of
intestinal crypts. These Paneth cells, by elaborating key short-
range growth factors like Wnt3, EGF, and Notch ligands, are
necessary for the in vivo maintenance of Lgr5+ ISCs such that
depletion of Paneth cells in genetic mouse models results in
the coordinated loss of Lgr5+ stem cells (Geiser et al., 2012;
Sato et al., 2011). Endothelial and perivascular cells near the
endosteumprovide necessary short-range growth factors to fos-
ter HSCmaintenance where genetic deletion of StemCell Factor
in these niche cells leads to the loss of stem cells (Ding et al.,
2012; Kiel et al., 2005). Similarly, hair follicle stem cells require
activating short-range signals from the dermal papilla to initiate
growth and regeneration of the hair follicle (Folgueras et al.,
2013; Greco et al., 2009). Thus, local cues emanating from the
stem cell niche are key governors of diverse stem cell pools.
Although little is known about howmammalian stem cells inte-
grate long-range systemic factors, stem cells may have intrinsic
and extrinsic (via their niches) mechanisms for sensing diet-
induced organismal physiology to alter tissue composition and
growth (Figure 1). Neural stem cells possess intrinsic machinery
for sensing IGF2 in the cerebral spinal fluid to fuel their prolifera-
tion (Lehtinen et al., 2011; Nakada et al., 2011). In other cases,
the niche in response to long-range systemic factors extrinsically
regulates stem cell function. For example, thyroid hormone pro-
motes neurogenesis by modulating the adult neural stem cell
niche (Lo´pez-Jua´rez et al., 2012). Another example is the intes-tine where Paneth cells control stem cell function in response
to organismal feeding (discussed later) (Yilmaz et al., 2012).
Also, recent work demonstrates that sex influences how adult
stem cells sense organismal cues. HSCs from males and
females, for instance, differentially respond to circulating estro-
gen, probably allowing for enhanced hematopoiesis in females
during pregnancy (Nakada et al., 2014). Thus, diverse mecha-
nisms regulate stem cell fate in response to local and organismal
demands.
Diet and Stem Cell Homeostasis
Calorie Restriction
Given that calorie restriction delays age-related pathologies and
increases lifespan in diverse species, it has been proposed that
it does so in part by preserving stem cell numbers, function, or
both in multiple tissues. Calorie restriction boosts the regener-
ative capacity of stem cells in multiple rodent tissues. In the
CNS, for example, calorie restriction promotes the generation
of new neurons in the dentate gyrus. In the blood system, calorie
restriction prevents the decline of HSCs with age in certain
genetic backgrounds (Chen et al., 2003; Ertl et al., 2008). From
these studies, however, it is unclear whether calorie restriction
mediates its effects intrinsically or extrinsically via short- and/
or long-ranged signals on stem cells.
Recent work by Wagers and colleagues has raised the possi-
bility that both stem-cell-intrinsic and -extrinsic regulatorymech-
anisms are at play in boosting rodent skeletal muscle stem
cell activity in short-term calorie restriction (Figure 1B) (Cerletti
et al., 2012). Short-term calorie restriction enhances skeletal
muscle stem cell frequency in young and aged mice, improving
muscle regeneration after injury. In functional assays, calorie re-
striction-derived stem cells are more potent inducers of muscle
regeneration when transplanted into the injured muscle of con-
trol recipients, indicating that calorie restriction exerts at least
some of its effects directly on stem cells. Muscle stem cells
from calorie-restricted mice not only had more mitochondria
than their control counterparts, but these mitochondria were
more adept at consuming oxygen for energy (ATP) production.
These data suggest that metabolic plasticity allows stem cells
to adapt to low-calorie states by skewing their metabolism
toward oxidative phosphorylation from glycolysis. This shift
toward augmented oxidative phosphorylation promotes stem
cell function in the muscle.
Interestingly, however, the physiological environment induced
by calorie restriction may also play an integral role in mediating
these effects in stem cells as isolated muscle stem cells from
ad-libitum-fed mice manifested better engraftment and regen-
eration when transplanted into the injured muscle of calorie-
restricted hosts. Although it is still unclear mechanistically how
the altered stem cell microenvironment in calorie restriction
modulates muscle stem cell function, the authors speculate
that a reduction in inflammation, a known effect of calorie restric-
tion, boosts muscle repair after injury and the capacity of muscle
stem cells to engraft in transplanted muscle.
Obesity
The obesity epidemic has increased significantly over the last
several decades and underlies a multitude of ‘‘metabolic syn-
drome’’-associated disorders such as increased carbohydrate
intolerance leading to insulin resistance and type II diabetes,Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc. 293
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Figure 1. Dietary Regulation of Stem Cells in Tissue Homeostasis
(A) Intrinsic (dark green) and extrinsic (orange) diet-sensing mechanisms integrate diet-induced physiology with tissue homeostasis. Stem cells (blue) and their
niche (green) sense physiologic cues such as hormones, growth factors, and nutrients to dynamically alter the production of differentiated cells (pink).
(B) Calorie restriction boosts regeneration in diverse tissues by increasing stem cell numbers and function. Niche-derived signalsmediate some of the response of
calorie restriction on stem cells.
(C) Diet-induced obesity is associatedwith an abundance of nutrients, growth factors, and hormones that eventually leads to physiologic disequilibrium, including
insulin resistance, diabetes, and metabolic syndrome. This state reduces tissue repair, in part due to dysfunction of stem cells, their niches, or both.
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temic inflammation, and increased incidence of certain types
of cancers (Coughlin et al., 2004; Strickler et al., 2001; Vigneri
et al., 2006). With high rates of adult and now childhood obesity
on the rise, the metabolic syndrome epidemic has become one
of the leading causes of preventable death and continues to be
an increasing burden on healthcare costs internationally.
Obesity, a chronic pathologic condition, is most frequently
associated with surplus of caloric intake compared to caloric
expenditure. One of the many consequences of the obese state
is that individuals have an imbalance of endocrine hormonal
signaling, such as increased insulin and leptin and decreased
adiponectin, which collectively are associated with insulin resis-
tance. Obesity is coupled with hormone and cytokine signaling
deregulation that impede tissue repair after injury. For example,
diabetic patients as well as diabetic and high-fat diet (HFD)-
induced obese mice exhibit delayed wound closure, explained
partially by defects in myofibroblast differentiation (Seitz et al.,
2010). Adipose-derived mesenchymal stem cells from obese
patients showed skewed differentiation potential in ex vivo func-294 Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc.tional assays (On˜ate et al., 2012). In general, chronic obesity is
associated with changes that decrease wound healing.
Recently, studies have implicated obesity and its associated
disorders on the regulation of stem cell function in vivo. Both
in rodent models of type 1 and 2 diabetes and in diabetic
patients, HSCs were less effective at mobilizing out of their
bone marrow environment into the systemic circulation (Ferraro
et al., 2011; Rafalski et al., 2012). Further, when HSCs from
ad-libitum-fed mice were transplanted into diabetic hosts, the
HSCs displayed early proliferation, highlighting the extrinsic
influence of the diabetic environment on HSC proliferation
(Figure 1C). In addition, there is evidence suggesting that lipo-
proteins differentially control HSC proliferation, where low-den-
sity lipids (LDLs) promote and high-density lipids (HDLs) inhibit
HSC numbers (Feng et al., 2012; Murphy et al., 2011). Also,
hormones elevated in obesity, such as leptin, may enhance
HSC numbers. Exogenous leptin augmented phenotypic HSC
numbers and function in ex vivo culture, but it is unclear whether
leptin does so in transplantation assays or in obesity (Dias et al.,
2013; Mukouyama et al., 1998). Interestingly, a component of
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question of whether obesity-related changes in HSC function
are mediated by the response of their niche to elevated leptin
(Ding et al., 2012).
Another population of somatic stem cells that may be affected
by HFD is hypothalamic neural stem cells. Two studies in 2012
demonstrated that there are Nestin and Sox2-positive neuro-
genic stem cells residing in the hypothalamus that are sensitive
to the effects of high-fat diet (Lee et al., 2012; Li et al., 2012). Li
and colleagues demonstrated that HFD led to a reduction of
hypothalamic stem cell numbers, as well as neurons produced
from these cells. Interestingly, prolonged HFD for 8 months led
to a 10% decrease of major types of hypothalamic neurons,
which also include POMC neurons that regulate feeding
behavior. Conversely, Lee and colleagues reported an increase
of neuronal output and neurogenesis after a short-term HFD
regimen. These studies indicate that the response to acute
and chronic obesity may differentially regulate neural progenitor
biology.
Altered organ function in obesity may correlate with increased
intraorgan fat. Obese individuals are predisposed to hepatic
steatosis or nonalchoholic fatty liver disease (NAFLD). More
advanced disease leads to liver cirrhosis, an irreversible state
in which the liver can no longer regenerate and adequately repair
itself. Repair to injury in the liver is driven by bipotent oval cells
that generate new hepatocytes and bile duct epithelium (Yanger
and Stanger, 2011). Oval cells accumulate in mouse models of
fatty liver disease and other chronic liver diseases (Lowes
et al., 1999; Roskams et al., 2003). A recent study also showed
that injury in the liver leads to induction of Lgr5+ oval cells that
were able to generate liver organoids in vitro and can differen-
tiate into mature hepatocytes in transplantation assays (Huch
et al., 2013). Although the oval cell pool increases in response
to obesity-induced liver damage, it is unclear whether this con-
tributes to hepatocellular carcinoma.
HFD-induced obesity also hampers muscle repair after injury,
resulting in smaller muscle fibers (Hu et al., 2010). These effects
were noted to occur in the absence of impaired satellite cell pro-
liferation, as assessed by Brdu incorporation, consistent with the
notion that high-fat diet may have extrinsic effects on muscle
differentiation and maturation. One possibility is that HFD en-
hances inflammatory signals, which then delay proper muscle
regeneration (Figure 1C). This model fits with the findings that
calorie restriction may improve muscle regeneration upon injury
through decreased inflammation.
Pathways Regulated by Organismal Diet in Stem Cells
Because substrates such as glucose, amino acids, and fatty
acids will vary based on the composition of distinct dietary inter-
ventions, an important question is how changes in nutrition are
translated to altered stem cell function. Recently, regulation of
the phosphatidylinositol 3-kinase/AKT (PI3K/AKT) growth factor
pathway by insulin, the mechanistic target of rapamycin (mTOR)
pathway by nutrients, the AMPK/LKB1 pathway by energy, and
the Sirtuins through NAD+ levels have been implicated in medi-
ating many of the beneficial and deleterious effects of calorie re-
striction and obesity on stem cell function and cancer initiation.
These pathways have also been shown to play a critical role in
the regulation of metabolic processes such as glycolysis andoxidative phosphorylation that are reviewed in Ochocki and
Simon (2013), Shyh-Chang et al. (2013), Rafalski et al. (2012),
and Folmes et al. (2012).
mTOR in HSCs and Leukemia Initiation
Many of the organismal benefits of calorie restriction on tissue
function have been linked to the regulation of mTOR (Johnson
et al., 2013). mTOR is the target of an FDA-approved compound
named rapamycin and interacts with associated proteins to form
two distinct complexes: mTOR complex 1 (mTORC1) and com-
plex 2 (mTORC2) that have overlapping and distinct functions as
well as different sensitivities to rapamycin inhibition (Laplante
and Sabatini, 2012). mTOR has distinct functions depending
on the protein complex that it nucleates. mTORC1 is a master
integrator that couples cellular and organismal growth by re-
sponding to diverse upstream signals that include oxygen,
amino acids, and energy levels. Growth factors, such as insulin,
activate the PI3K/AKT pathway, which in turn leads to the stim-
ulation of mTORC1 by inhibiting the tuberous sclerosis complex
1/2 (Inoki et al., 2002). The mTORC1 pathway promotes growth
by stimulating protein and lipid synthesis. ThemTORC2 pathway
regulates survival and metabolism by phosphorylating AKT,
which bridges signaling between the two distinct mTOR com-
plexes (Figure 2).
Insights into the role of mTOR in stem cell fate regulation came
from studies in which phosphatase and tensin homolog (PTEN),
a phosphatase that negatively regulates signaling through the
PI3K/AKT, was deleted in HSCs (Yilmaz and Morrison, 2008;
Yilmaz et al., 2006; Zhang et al., 2006). Deletion of PTEN or en-
forced genetic activation of AKT stimulated HSC proliferation
and depletion and led to the development of acute leukemia
(Kharas et al., 2010; Yilmaz et al., 2006). Treatment with rapamy-
cin reversed the decline of PTEN-deficient HSCs and prevented
the formation of acute leukemia, implicating mTORC1 as a
key intrinsic regulator of not only HSC identity, but also of
leukemia-initiating cells (cells capable of transferring leukemia
upon transplantation). In subsequent studies, deletion of TSC1
(a negative regulator of mTORC1 but not of PI3K) in HSCs led
to the loss of HSCs within weeks (Chen et al., 2008; Gan et al.,
2008) by increasing mitochondrial biogenesis and reactive oxy-
gen species (ROS). TSC1-deleted HSCs could be rescued by
treatment with rapamycin or partially with antioxidant n-acetyl
cysteine (NAC). In contrast to PTEN deficiency, TSC1 loss
in HSCs did not lead to the generation of acute leukemia, indi-
cating that pathways independent of mTORC1 are required for
leukemogenesis.
An important question is how does chronic mTORC1 stimula-
tion lead to stem cell depletion. Recent work by Morrison and
colleagues demonstrated that Pten deletion activates a tumor-
suppressive response in HSCs (Lee et al., 2010). PTEN deletion
induces expression of p16INK4a and p53 in HSCs during
the depletion phase of stem cells, and this increase in tumor
suppressor gene expression is ameliorated by treatment with
rapamycin, placing this response downstream of mTOR. The
activation of a senescence response is likely to protect the
stem cell pool from acquiring secondary mutations that lead to
the formation of leukemia. Indeed, loss of tumor suppressors
p16INK4a, p53, or both rescues the depletion of stem cells but
with the deleterious side effect of accelerating the generation
of transplantable leukemia-initiating cells (Figure 3).Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc. 295
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Figure 2. Diet-Sensing Pathways in Stem Cells
Growth factor binding to receptor tyrosine kinases activates phosphatidylinositol 3-kinase (PI3K) and PTEN suppresses signaling through this pathway. PI3K and
mTORC2 activate AKT, which regulates mTORC1 activity by inhibition of the TSC1/TSC2 complex. Independently, the Rag-GTPases control mTORC1 activity in
response to nutrients, such as amino acids and glucose, at the lysosome surface. Multiple pathways downstream of active mTORC1 control anabolic processes,
including protein and lipid synthesis, and inhibit catabolic processes like autophagy. S6 kinase 1 (S6K1) regulates protein synthesis and ribosome biogenesis and
4E-BP1 regulates cap-dependent protein translation. Deletion of PTEN or TSC1 leads to the activation of mTORC1 and to stem cell depletion. Treatment with
mTORC1 inhibitor rapamycin restores loss of stem cell function. The energy sensor AMPK becomes activated in response to glucose starvation and relative
increases in the ratio of AMP and ADP to ATP levels. AMPK is phosphorylated and activated in an AMP-dependent manner by the upstreammaster kinase LKB1
and in turn negatively regulates mTORC1 to promote catabolic, energy producing processes such as autophagy and fatty acid oxidation. Another intracellular
sensor, SIRT1, becomes activated in response to relative increases in the ratio of NAD+ to NADH to regulate the activity of FOXO transcription factors. FOXO
family members control expression of genes involved in oxidative stress, cell death, cell-cycle control, and metabolism, which are important for stem cell
maintenance.
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by targeting mTORC2, which acts upstream of mTORC1.
mTORC2 phosphorylates AKT at Ser473, which in turn leads to
the activation of mTORC1. Interestingly, deletion of Rictor, an
essential mTORC2 component, has no effects on normal hema-
topoiesis but prevents HSC loss and leukemogenesis in PTEN-
deficient HSCs. These findings indicate that although mTORC2
is dispensable for normal stem cell function, it is critical for
leukemia-initiating cells in the setting of enforced PI3K/AKT
signaling. Similar to HSCs, many tissues have stem cells that
tolerate complete loss of mTORC2 signaling, such as the he-
matopoietic, intestine,muscle, and prostate, raising the question
of whether mTORC2 inhibitors can target neoplastic growth with296 Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc.minimal toxicity to normal stem cells (Bentzinger et al., 2008;
Guertin et al., 2009; Magee et al., 2012a; Yilmaz et al., 2012).
In contrast tomTORC2, inhibition of mTORC1 requires precise
control in order to preserve stem cell function. Complete genetic
loss of mTORC1 is detrimental for HSC maintenance: deletion
of Raptor, a necessary component of the mTORC1 complex,
causes progressive hematopoietic failure and is required for
HSC regeneration (Hoshii et al., 2012; Kalaitzidis et al., 2012).
However, partial inhibition of mTORC1 with rapamycin generally
enhances stem cell self-renewal. For instance, rapamycin aug-
ments stem cell numbers in the intestine and blood and boosts
the repair capacity of mucosal stem cells in radiation-induced
mucositis (Huang et al., 2012; Iglesias-Bartolome et al., 2012;
Figure 3. The PI3K-mTOR Axis in HSCs and
Leukemia Initiation
The PI3K-mTOR pathway and possible mecha-
nism of HSC depletion and leukemia initiation.
mTOR kinase nucleates two complexes: mTORC1
and mTORC2. mTORC2 is upstream of mTORC1
and activates AKT, which in turn induces down-
stream mTORC1 signaling. Deletion of PTEN
leads to hyperactivation of AKT and inactivation of
the TSC1/TSC2 complex to activate mTORC1.
Chronic mTORC1 signaling leads to the induction
of tumor suppressor genes, such as p16INK4a,
p19ARF, and p53, in stem cells. Treatment with
rapamycin rescues this response in stem cells,
restoring normal function. Although PTEN is
required for the maintenance of HSCs, its loss
gives rise to leukemia-initiating cells (or cells
capable of transferring acute leukemia to recipient
mice). Secondary mutations that inactivate the
tumor-repressive response in PTEN-deletedHSCs
are probably required for leukemogenesis. Dele-
tion of Raptor or Rictor, essential components of
mTORC1 or mTORC2, respectively, or adminis-
tration of rapamycin delay the decline in HSCs and
the generation of leukemia with PTEN deficiency.
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date the relationship of rapamycin-sensitive and -insensitive
mTORC1 substrates to stem cell maintenance.
Also, there is some evidence suggesting that sustained mTOR
signaling accounts for some of the decline in stem cell function
with age. HSCs isolated from one genetic strain of old mice
showed evidence for increased mTOR signaling, although the
mechanism of how mTOR signaling increases with age in
HSCs is unknown (Chen et al., 2008). Interestingly, the age-
related decline in the reconstituting capacity of HSCs, as well
as defects in differentiation, was attenuated by rapamycin. How-
ever, the extent to which rapamycin actually rescues the aging
phenotype is unclear as rapamycin also boosts the absolute
numbers of HSCs in young mice (Huang et al., 2012; Nakada
et al., 2010; Signer and Morrison, 2013). These beneficial effects
of rapamycin on hematopoiesis may be secondary to its effect
on increasing stem cell numbers rather than in rejuvenating
aged HSC function; more studies will be needed to distinguish
between these possibilities.
mTOR in Other Somatic Stem Cells
Sustained mTOR activity, outside of the hematopoietic system,
also drives stem cell exhaustion. For example, persistent growth
signaling byWnt1 in the mouse epidermis caused hair follicle hy-
pertrophy followed by loss of hair follicles and stem cells (Cas-
tilho et al., 2009). Although Wnt1 activated both b-catenin and
mTORC1, treatment with rapamycin restored normal hair follicleCell Stem Cellgrowth and prevented stem cell deple-
tion, highlighting the prevalent role
of mTORC1 in this process. mTORC1
signaling also plays a dominant role in
spermatogonial stem cell maintenance
(Hobbs et al., 2010). The promyelocytic
leukemia zinc finger (PLZF) transcription
factor tunes stem cell mTORC1 activity
via transcriptional control of Redd1, an
mTORC1 inhibitor protein, in responseto niche-derived signals. Genetic deletion of Plzf results in sper-
matogonial stem cell depletion in an mTORC1-dependent
manner that can be prevented with rapamycin. Critical control
of mTOR signaling is essential for stem cell maintenance in
diverse tissues.
The mTOR pathway is also important for the extrinsic regula-
tion of stem cell fate. The mammalian small intestine, for
example, undergoes structural changes (shorter villi with less
numbers of differentiated enterocytes) in response to calorie
restriction, indicating that diet-induced physiology alters tissue
composition. At the level of the stem cell, calorie restriction in
the mouse intestine dampens mTORC1 signaling in Paneth cells
(a component of the stem cell niche) but not in stem cells them-
selves, resulting in an increase in both stem cell and Paneth cell
numbers (Yilmaz et al., 2012). Mechanistically, reduced niche-
dervied mTORC1 activity induces the expression of bone stro-
mal antigen 1, an ectoenzyme that produces the paracrine factor
cyclic ADP ribose (cADPR), in Paneth cells to bolster the prolifer-
ation of ISCs. Interestingly, instead of directly targeting mTORC1
signaling in ISCs, calorie restriction and rapamycin treatment
create amore favorable stem cell niche. Preserving or increasing
the intestinal stem cell pool in low-calorie states may keep
intestinal stem cells in a poised state, allowing them to rapidly
regenerate the depleted differentiated cell types once nutrients
become available. This poised state may be one mechanism
that enables mammalian tissues to adapt to intermittent famine.14, March 6, 2014 ª2014 Elsevier Inc. 297
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Energy sensing is differentially regulated between stem cells and
their progeny and may also influence mammalian lifespan. The
AMP-activated kinase (AMPK) is a master sensor of changes
in the ratio of AMP to ATP (Hardie et al., 2012). During periods
of low-energy stress, such as food deprivation, AMPK becomes
activated as the concentrations of AMP and ADP increase.
Activated AMPK subdues anabolic cellular processes, such
as mTOR-mediated growth and lipogenesis, and activates
catabolic processes, such as autophagy, to preserve energy.
Intriguingly, recent data indicate that metformin, a commonly
prescribed drug for type 2 diabetes that activates AMPK, may
phenocopy some of the health and lifespan benefits of calorie re-
striction in male rodents (Martin-Montalvo et al., 2013). Although
it is unclear from this study whether reduced mTOR signaling
accounts for some of these beneficial effects, metformin-
treated rodents manifest calorie restriction-like gene expression
changes and metabolic responses.
In addition to being a direct sensor of energy, AMPK is also
under the control LKB1 kinase (also called STK11). LKB1 is a
master regulator kinase that functions as a tumor suppressor
and activates AMPK in response to low intracellular energy levels
(Figure 2) (Shackelford and Shaw, 2009). In addition to phos-
phorylating AMPK, LKB1 also phosphorylates and regulates
several other families of kinases related to AMPK, although
phosphorylation of AMPKa1 and AMPKa2 are the only ones
whose phosphorylation is regulated through changes of AMP/
ADP to ATP levels (Hardie and Alessi, 2013; Mihaylova and
Shaw, 2011). LKB1 has an essential role in HSC maintenance
that is independent of the AMPK-mTOR pathway. In three sepa-
rate studies, LKB1 deletion led to the transient expansion but
eventual depletion of HSCs, leading to pancytopenia (or loss of
all blood cell types) (Gan et al., 2010; Gurumurthy et al., 2010;
Nakada et al., 2010). LKB1 was intrinsically necessary for HSC
function, as LKB1-deleted HSCs or whole bone marrow cells
were incapable of regenerating the hematopoietic system of
control mice. LKB1 deficiency did not induce mTORC1 activity
in HSCs and their function was not restored by rapamycin.
Further, administration of small-molecule AMPK activators did
not prevent the decline of LKB1-deleted HSCs. Nakada et al.
also tested the necessity of AMPK by deleting its two catalytic
subunits in HSCs. Although AMPK deletion in HSCs reduces
their numbers, AMPKwas dispensable for HSC function in trans-
plantation assays. Loss of either LKB1 or AMPK reduced mito-
chondrial membrane potential and function, but LKB1 played
an AMPK-independent role in maintaining the genomic integrity
of stem cells. It is important to note, however, that the effects of
LKB1 on stem cell maintenance may be specific to certain types
of tissues, as deletion of LKB1 in the intestine alters differentia-
tion of secretory cells with no appreciable effect on ISC mainte-
nance (Shorning et al., 2009). Future studies will need to address
why some stem cell pools tolerate LKB1 loss while others do not.
Insulin Signaling and FOXO
Insulin signaling regulates lifespan in diverse species, ranging
from worms to mammals (Kenyon, 2010). Mutations in rodents
that reduce insulin signaling extend lifespan, and reduced
levels of circulating insulin and IGF-1 are hallmarks of calorie
restriction (Kenyon, 2010). Insulin signaling via PI3K/AKT acti-
vates mTOR and non-mTOR-dependent effectors. One set of298 Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc.substrates inhibited by AKT and not regulated by mTOR in-
cludes the DNA-binding forkhead box O (FOXO) transcription
factors. Upon phosphorylation by AKT, the FOXO transcription
factors are excluded from the nucleus through 14-3-3 bind-
ing. FOXO transcription factors control critical physiological
processes that include cell proliferation, survival, and induce
the expression of detoxifying enzymes, such as catalase
and manganese superoxide dismutase (Figure 2) (Greer and
Brunet, 2005). Sustained AKT activation, therefore, increases
intracellular ROS levels, which leads to ROS-induced dam-
age and apoptosis. Interventions that lead to reduced
insulin signaling, such as calorie restriction, keep intact the
FOXO transcription program that allows for oxidative stress
response.
FOXO family members play an important role in stem cell
maintenance. In the hematopoietic system, conditional ablation
of FOXO1, FOXO3a, and FOXO4 or just FOXO3a led to the loss
of HSCs through the increase of ROS production but not to the
generation of acute leukemia (Miyamoto et al., 2007; Tothova
et al., 2007). Similar to PTEN- and TSC-deleted stem cells,
FOXO-deleted HSCs were unable to regenerate the hemato-
poietic system of recipient mice. Many of the effects of FOXO
deficiency in HSCs could be restored by treatment with the anti-
oxidant NAC. FOXO3a suppression of ROS in HSCs required the
tumor suppressor protein ataxia telangiectasia mutated (ATM),
and induction of ROS in FOXO3-deficient HSCs led to the induc-
tion of the tumor suppressor p53 (Ochocki and Simon, 2013;
Yalcin et al., 2008). While rapamycin treatment restores HSC
function upon PTEN or TSC deficiency, rapamycin does not
rescue the effects of FOXO deficiency in HSCs, indicating that
the mechanism of HSC depletion with mTOR activation and
FOXO deficiency are distinct.
FOXO transcription factors also play an important role in
neural stem cell homeostasis in part through redox homeostasis
(Paik et al., 2009; Renault et al., 2009; Webb et al., 2013; Yeo
et al., 2013). For example, loss of FOXOs in neural stem and
progenitor cells enhanced brain size and neural progenitor pro-
liferation, which eventually caused the depletion of neural stem
cells and reduced neurogenesis (Paik et al., 2009; Renault
et al., 2009). These studies indicate that FOXOs constrain
stem cell proliferation and maintain the self-renewal program in
diverse adult stem cell populations.
Recent evidence also implicates FOXO3a in HSCs as an
important mediator of a proautophagic response to acute food
deprivation (Warr et al., 2013). HSCs, but not their downstream
progeny, are exquisitely capable of activating autophagy,
permitting them to withstand periods of nutrient and growth fac-
tor fluctuations. Although FOX3A is essential for poising stem
cells for autophagy, there is considerable interaction between
the LKB1/AMPK pathway, insulin signaling, and mTOR, which
is also a potent inhibitor of autophagy. In addition to activation
of FOXO3a with food deprivation, a potential mechanism may
also involve the parallel attenuation of mTOR signaling by either
reduced insulin signaling or activation of AMPK to initiate the
autophagic response to allow stem cells to endure.
Sirtuins
There are sevenmembers that comprise themammalian Class III
deacetylase family of Sirtuins. The Sirtuins, which have NAD-
dependent deacetylase activity to both histone and non histone
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a number of model organisms (Bordone et al., 2007; Fang and
Nicholl, 2011; Herranz et al., 2010; Yu and Auwerx, 2009; Zhang
et al., 2011). Recently, several studies have suggested that
changes in NAD+ levels occur with aging and alterations of
NAD+ production or consumption can modulate healthspan
and lifespan in a sirtuin-dependent manner (Canto´ et al., 2012;
Mouchiroud et al., 2013; Yoshino et al., 2011). SIRT1 bears the
greatest sequence homology to the yeast Sir2, which has been
shown to increase yeast lifespan (Kaeberlein et al., 1999), and
is the best-studied mammalian member in the context of stem
cell biology and aging (reviewed in Rafalski et al., 2012).
The role of SIRT1 in mammalian adult stem cell biology is
perhaps best studied in the hematopoietic system. Multiple
studies have examined the role of SIRT1 in HSCs. SIRT1-loss
had little effect on HSCs and downstream progenitor numbers
and function (Leko et al., 2012). This perhaps can be explained
by upregulation or compensation by another sirtuin family mem-
ber (Narala et al., 2008). In contrast, SIRT1 has been implicated
in the homeostasis of neural stem cells. Deletion of SIRT1 was
shown to lead to impaired neuronal differentiation and
conversely its overexpression improved differentiation (Hisahara
et al., 2008). Further, SIRT1-deficient mice have been reported to
exhibit neuronal defects in certain mouse backgrounds (Cheng
et al., 2003; McBurney et al., 2003). SIRT1 has also been demon-
strated to limit the size of the oligodendrocyte progenitor pool
(Rafalski et al., 2013).
Recently it has been suggested that the mitochondrial sirtuin
SIRT3 may regulate aspects of HSC aging. SIRT3 is dispensable
for HSC maintenance in young mice but its expression declines
with age. Interestingly, when re-expressed in aged cells, it re-
stores HSC function (Brown et al., 2013). Regulation of stem cells
by the Sirtuins may contribute to aspects of tissue regeneration
and aging.
Diet, Stem Cells, and Cancer Incidence
Calorie Restriction
Calorie restriction is a dietary intervention that not only promotes
health and lifespan in diverse species but also has potential anti-
cancer effects. Moreschi first observed in 1909 that calorie re-
striction negatively influenced tumor growth, and since then
the effects of calorie restriction on cancer incidence and pro-
gression have been extensively studied in numerous genetic
mouse models and in xenograft experiments (Kritchevsky,
1999). It is generally observed that the calorie restriction state re-
tards tumor growth, but its effects on cancer initiation are less
certain (Longo and Fontana, 2010). There are models in which
calorie restriction has been reported to reduce tumor initiation
and others in which it has no effect (Longo and Fontana, 2010).
The mechanisms for the anticancer growth effects of calorie
restriction are probably multifactorial. A dominant effect of calo-
rie restriction involves a reduction in circulating systemic factors
(e.g., hormones and growth factors), which may protect against
cancer. Long-term calorie restriction, for instance, attenuates
serum IGF-1 levels by 30%–40%, and the antitumor initiation
and progression effects of calorie restriction can be rescued
by infusions of exogenous IGF-1 (Dunn et al., 1997; Longo and
Fontana, 2010; Tomas et al., 1994). Consistent with the notion
that reduced growth factor signaling curtails tumor growth,tumors that harbored activatingmutations in the insulin-signaling
pathway are resistant to calorie restriction (Kalaany and Sabatini,
2009). In addition, mouse FOXO1was shown to be necessary for
some of the antitumorigenic effects of calorie restriction, but
whether FOXO is needed for increasing longevity in mammals
in response to dietary restriction remains to be seen (Yamaza
et al., 2010). Although sensitivity to insulin signaling is a key fac-
tor that predicts antigrowth responsiveness to calorie restriction,
adaptations involving diverse hormones such as corticosteroids
and sex hormones, DNA repair mechanisms, and antioxidant
proteins as reviewed in Longo and Fontana (2010) may also
contribute.
Given that adult stems reside at the crossroads of responding
to the physiologic consequences of diet and often accumulate
mutations that lead to transformation, a prediction would be
that dietary interventions in which there is a durable increase in
stem cell numbers may over the long-term boost the number
of target cells that can undergomutagenesis (Figure 4B). A larger
stem cell pool provides more potential substrates that are
capable of acquiring mutations. As described earlier, paradoxi-
cally, calorie restriction bolsters the numbers, proliferation, or
both of stem cells in young and old mice in multiple tissues,
yet there are conflicting reports as to the effects of calorie restric-
tion on tumor initiation in these same tissues. In the intestine,
for example, calorie restriction enhances the numbers of Lgr5+
ISCs, which are also the cell of origin for intestinal precancerous
adenomas. Studies assessing tumor initiation in the calorie-
restricted intestine in the same strain of mice and using the
same or different (Tsao et al., 2002) genetic cancer models
come to divergent conclusions. In general, all of these studies
report a reduction in the overall size of adenomas consistent
with the antigrowth effects of calorie restriction, but in terms of
incidence some report either a neutral or negative effect (Kakuni
et al., 2002; Mai et al., 2003). In another study by Weindruch
and colleagues, calorie restriction, when started in middle-
aged mice, actually increased the incidence of spontaneous
cancers (Pugh et al., 1999). Many factors such as composition
and type of diet, the extent of calorie restriction, genetic model
and background, and tissue type examined may differentially
affect how calorie restriction influences tumor initiation.
In some cases, it may be difficult to segregate the antigrowth
and anti-initiation effects of calorie restriction, particularly with
respect to how increased numbers of stem cells influence tumor
initiation. Perhaps the antigrowth effects of calorie restriction
cloak some of its effects on tumor initiation. It is possible, for
example, that in some instances calorie restriction increases
tumor incidence but that these lesions are below the threshold
of detection because they are small in size. Another possibility
is that stem cells under calorie restriction, although more
numerous, have adapted autonomous strategies to enhance
genomic stability and DNA repair and reduce oxidative damage.
Such adaptations may neutralize the effects of a larger, more
robust stem cell pool. It is also possible that nonautonomous
changes induced by calorie restriction, like improved immu-
nosurveilance, compensate for increased tumor initiation by
causing regression of early cancers (Figure 4B). More studies
will be required to distill the mechanism of how the interplay
between calorie restriction and a more active stem cell reservoir
contribute to cancer incidence.Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc. 299
A B C
Figure 4. Diet and Cancer Initiation
(A) In tissues that follow a stem cell paradigm, stem cells (red) acquire early oncogenic events (red arrow) that lead to transformation and tumor formation.
(B) Calorie restriction augments stem cell numbers and function in diverse tissues and is proposed to have antitumor initiation and growth effects. If stem cell
numbers increase with calorie restriction and they undergo some of the early changes that give rise to tumors, calorie restriction may potentially increase tumor
incidence. It is possible that autonomous and nonautonomous protective mechanisms are activated in stem cells with calorie restriction, which neutralize the
effects of a larger, more robust stem cell pool. Another possibility may be that the antigrowth effects of calorie restriction on tumor growth mask its effects on
initiation. Tumors arising in calorie restriction may remain below detection threshold because they are small in size.
(C) Diet-induced obesity has untoward effects on tissue repair and cancer incidence. Although stem cell numbers can decrease with chronic obesity, the
susceptibility of differentiated cells to undergo transformation can also increase as has been noted to occur with inflammation. In this case, early oncogenic
events can occur in stem cells and differentiated cells, effectively increasing the pool of cells that can undergo early transformation. Surplus growth factors,
nutrients, and hormones then drive tumor progression and growth.
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Another type of diet that has been suggested to have an impact
on cancer formation and progression is the ketogenic diet (KD).
KD is defined as a diet rich in fat, sufficient in protein, and low in
carbohydrates. The reduction of carbohydrates leads to a sub-
sequent decrease of glucose utilization and an increase in the
use of ketone bodies as an alternative energy source. One of
the tissues impacted the most from a reduction of glucose utili-
zation is the brain. In fact, ketogenic diets have been used as an
alternative therapy to reduce the incidence of seizures in children
with epilepsy (Hartman and Vining, 2007). Some of the proposed
mechanisms for the success of ketogenic diets are the inhibition
of glycolysis, changes in activation of ATP-sensitive potassium
channels, and altered transmission of glutamatergic synapses
(Freeman et al., 2007; Lefevre and Aronson, 2000). Some studies
utilizing a ketogenic diet have also supported its beneficial ef-
fects in vitro and inmousemodels of cancer, although not always
with positive effects.
Recently, ketogenic diets have been proposed as a therapeu-
tic additive in the treatment of glioblastoma multiforme and
several clinical trials have included KD in a combined therapy
(Seyfried et al., 2012). The calorie-restricted KD diet relies
on shifting the energy source of glioblastoma cells to ketone
bodies from glucose in conjuction to inducing pathways
mimicking calorie restriction, which may be beneficial for sur-
vival of normal neurons but induce cancer cell death (Zuccoli
et al., 2010). Several small studies have suggested that a calo-
rie-restricted ketogenic diet reduces tumor progression (Nebel-300 Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc.ing et al., 1995; Schmidt et al., 2011; Zuccoli et al., 2010). One
obvious benefit of the combined ketogenic calorie-restricted
diet includes a reduction in insulin signaling. However, the
differential effects of low-calorie intake versus the composition
of the ketogenic diet on stem cells and cancer needs more
examination.
Obesity
In addition to predisposing to diabetes and cardiovascular dis-
ease, a number of epidemiological studies over the past several
decades have demonstrated that overweight and obese individ-
uals have increased incidence of multiple different types of
cancers (Finucane et al., 2011). Obesity and elevated visceral
fat increase the incidence of gastroesophageal reflux disease
(GERD) and Barrett’s esophagus, which are risk factors for
esophageal cancer (Lo¨fdahl et al., 2011). The incidence of
colonic adenomas and carcinomas correlates with increased
body mass index (Calle and Kaaks, 2004; Ma et al., 2013; Oka-
bayashi et al., 2012). Supporting these findings are studies in
rodents that are subjected to high-fat diet with or without genetic
predispositions toward adenoma formation. Rodents fed a
western or high-fat diet have increased incidence in adenoma
numbers compared to mice fed normal chow (Baltgalvis et al.,
2009). Adenomas arising in mice fed a high-fat diet are larger
than those in calorie restriction, highlighting the opposing effects
of calorie restriction and high-fat diet on tumor growth (Mai et al.,
2003). In addition, several other cancers have been associated
with obesity such as postmenopausal breast and endometrial
cancer (Brown and Simpson, 2010).
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ward effects of obesity on stem cells and cancer. Insulin is a
mitogen that promotes the proliferation and growth of cancer
cells but also regulates tissue homeostasis (Figure 2) (Pollak,
2012). One possibility is that changes in growth factor and insulin
signalingmay increase the rate of senescence through increased
division of somatic stem cells as observed in PTEN-deficient
HSCs (Figure 3) (Lee et al., 2010). Chronic obesity may reduce
stem cell function and once these stem cells acquire secondary
mutations high levels of insulin and other systemic factors may
drive their proliferation. Another possibility is that a non-stem
cell population might compensate for reduced stem cell function
in chronic obesity to maintain tissue homeostasis and serves as
the cell of origin for some types of cancers, thus boosting the
pool of cells capable of becoming transformed.
In addition to systemic factors, numerous studies have impli-
cated the tumor microenvironment as also contributing to the
progression of cancer. Multiple studies have shown that adipo-
cytes can secrete progrowth factors to accelerate tumor growth
(Dirat et al., 2011; Tokuda et al., 2003). Supporting this notion,
it was recently reported that omental fat might attract ovarian
cancer cells through the releases of cytokine factors, where
inhibition of adipocyte-derived factors decreased tumor cell
migration ex vivo (Nieman et al., 2011). The ovarian cancer cells
reprogrammed their metabolism to feed off the lipid-rich micro-
environment.
Obesity-associated inflammation may also promote cancer
initiation and progression. Chemical irritants, pathogens, chronic
alcohol exposure, as well as dietary insults have all been shown
to lead to chronic inflammation and, in some cases, predispose
to certain types of cancer (Grivennikov and Karin, 2010; Hota-
misligil and Erbay, 2008). Inflammatory bowel disease, for
example, enhances the risk for developing colorectal cancer
(von Roon et al., 2007). It is interesting to note that not all persis-
tent inflammatory conditions augment tumorigenesis: rheuma-
toid arthritis and psoriasis, for example, do not increase cancer
risk. In fact, it has been suggested that low-grade inflammation
in psoriasis may have inhibitory effects on cancer (Grivennikov
and Karin, 2010; Nickoloff et al., 2005). At the molecular
level, multiple different pathways feed into inflammation. One
of the possible molecular connections between diet-dependent
inflammation and tumor progression is the activation of nuclear
factor- kB (NF-kB). NF-kB is activated in response to a number
of signaling pathways including inflammatory cytokines, tumor
necrosis factor a (TNF a), and activation of toll-like receptors.
ROS-mediated activation of NF-kB in the intestine connects
ISC proliferation to cancer initiation (Myant et al., 2013). Further-
more, activation of NF-kB in non-ISCs endowed these cells with
the capacity to initiate intestinal cancers (Schwitalla et al., 2013),
indicating that in inflammatory states cells capable of under-
going transformation are more diverse. One explanation for the
increase in cancer with obesity may include having a larger
pool of stem and non-stem cells that is susceptible to transfor-
mation (Figure 4C).
Conclusion
It has long been observed that diet has a profound influence
on tissue regeneration and cancer incidence. A better appreci-
ation for diet-sensing pathways and their effects on tissuehomeostasis and cancer initiation may lead to safer anticancer
and antiaging therapies. Dietary interventions that sustainably
drive regeneration by boosting stem cell numbers or function
may potentially run the risk of increasing cancer incidence. In
order to minimize this risk, future work will need to carefully
address not only how diet regulates stem cell fate but also
how these changes alter susceptibility to transformation in
stem cell and non-stem cell populations. The goal will be to
identify regulatory networks induced by dietary interventions
that safely enhance tissue repair and regeneration, while
minimizing cancer incidence. It will be also be interesting to
see how pharmacologic compounds that mimic aspects of
calorie restriction such as mTOR inhibitors or AMPK activators
perform as agents for enhancing stem cell function and tissue
repair in the elderly and obese. Lastly, given that some tumors
harbor populations with heterogeneous tumorigenic potential
of which some have cancer stem cell-like qualities, it will
be interesting to elucidate how these dietary interventions or
mimetics impact tumor heterogeneity and cancer stem cell
biology.
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